Frequency of medication errors in primary care patients with polypharmacy

Family Practice

Volumn 30, Issue 3, 2013, Pages 313-319

  Koper, Dara ^a   Kamenski, Gustav ^b,c   Flamm, Maria ^a   Böhmdorfera, Birgit ^a   Sönnichsena, Andreas ^d  

^a PARACELSUS MEDICAL UNIVERSITY   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c Karl Landsteiner Institute for Systematics in General Medicine   (Australia)

^d UNIVERSITY OF WITTEN HERDECKE   (Germany)

Author keywords

Chronic disease; Medical comorbidity; Medical errors patient safety; Pharmacology drug reactions; Primary care; Quality of care

Indexed keywords

AGED; ARTICLE; AUSTRIA; GENERAL PRACTICE; GERIATRIC PATIENT; HUMAN; MAJOR CLINICAL STUDY; MEDICATION ERROR; PATIENT CARE; POLYPHARMACY; PRIMARY MEDICAL CARE;

EID: 84878647133     PISSN: 02632136     EISSN: 14602229     Source Type: Journal    
DOI: 10.1093/fampra/cms070     Document Type: Article

References (23)

1. Marengoni A, Winblad B, Karp A, Fratiglioni L. Prevalence of multiple chronic diseases among the elderly population in Sweden. Am J Public Health 2008; 98: 1198-200.
2. Slabaugh SL, Maio V, Templin M, Abouzaid S. Prevalence and risk of polypharmacy among the elderly in an outpatient setting: a retrospective cohort study in the Emilia-Romagna region, Italy. Drugs Aging 2010; 27: 1019-28.
3. Junius-Walker U, Theile G, Hummers-Pradier E. Prevalence and predictors of polypharmacy among older primary care patients in Germany. Fam Pract 2007; 24: 14-9.
4. Thomsen LA, Winterstein AG, Sondergaard B, Haugbolle LS, Melander A. Systematic review of the incidence and characteristics of preventable adverse drug events in ambulatory care. Ann Pharmacother 2007; 41: 1411-26.
5. Hovstadius B, Hovstadius K, Astrand B, Petersson G. Increasing polypharmacy-an individual-based study of the Swedish population 2005-2008. BMC Clin Pharmacol 2010; 10: 16.
6. Feudtner C, Dai D, Hexem KR, Luan X, Metjian TA. Prevalence of polypharmacy exposure among hospitalized children in the United States. Arch Pediatr Adolesc Med 2012; 166: 9-16.
7. Wong CY, Chaudhry SI, Desai MM, Krumholz HM. Trends in comorbidity, disability, and polypharmacy in heart failure. Am J Med 2011; 124: 136-43.
8. Anthierens S, Tansens A, Petrovic M, Christiaens T. Qualitative insights into general practitioners views on polypharmacy. BMC Fam Pract 2010; 11: 65.
9. Schuler J, Dückelmann C, Beindl W, Prinz E, Michalski T, Pichler M. Polypharmacy and inappropriate prescribing in elderly internal-medicine patients in Austria. Wien Klin Wochenschr 2008; 120: 733-41.
10. The American Geriatrics Society 2012 Beers Criteria Update Expert Panel. American Geriatrics Society Updated Beers Criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2012; 60: 616-31.
11. Holt S, Schmiedl S, Thürmann PA. Potentially inappropriate medications in the elderly: the PRISCUS list for the elderly. Dtsch Arztebl Int 2010; 107: 543-51.
12. Garfinkel D, Mangin D. Feasibility study of a systematic approach for discontinuation of multiple medications in older adults: addressing polypharmacy. Arch Intern Med 2010; 170: 1648-54.
13. Gallagher P, Ryan C, Byrne S, Kennedy J, O'Mahony D. STOPP (Screening Tool of Older Person's Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment). Consensus validation. Int J Clin Pharmacol Ther 2008; 46: 72-83.
14. Garfinkel D, Zur-Gil S, Ben-Israel J. The war against polypharmacy: a new cost-effective geriatric-palliative approach for improving drug therapy in disabled elderly people. Isr Med Assoc J 2007; 9: 430-4.
15. Williams ME, Pulliam CC, Hunter R et al. The short-term effect of interdisciplinary medication review on function and cost in ambulatory elderly people. J Am Geriatr Soc 2004; 52: 93-8.
16. http://www.UpToDate.com/ (last accessed on 29 October 2012).
17. Levey AS, Stevens LA, Schmid CH et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150: 604-12.
18. http://webstore.lexi.com/lexi-interact (last accessed on 29 October 2012).
19. Thiem U, Theile G, Junius-Walker U et al. Prerequisites for a new health care model for elderly people with multimorbidity: the PRISCUS research consortium. Z Gerontol Geriatr 2011; 44: 115-20.
20. Mann E, Böhmdorfer B, Frühwald T et al. Potentially inappropriate medication in geriatric patients: the Austrian consensus panel list. Wien Klin Wochenschr 2012; 124: 160-9.
21. Essock SM, Schooler NR, Stroup TS et al. Effectiveness of switching from antipsychotic polypharmacy to monotherapy. Am J Psychiatry 2011; 168: 702-8.
22. Katon WJ, Lin EH, Von Korff M et al. Collaborative care for patients with depression and chronic illnesses. N Engl J Med 2010; 363: 2611-20.
23. Wehling M. Guideline-driven polypharmacy in elderly, multimorbid patients is basically flawed: there are almost no guidelines for these patients. J Am Geriatr Soc 2011; 59: 376-7.